Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: project of the Kyushu University Liver Disease (Q43047208)
Jump to navigation
Jump to search
scientific article published on 3 February 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: project of the Kyushu University Liver Disease |
scientific article published on 3 February 2008 |
Statements
1 reference
Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: project of the Kyushu University Liver Disease (English)
1 reference
Norihiro Furusyo
1 reference
Eiji Kajiwara
1 reference
Kazuhiro Takahashi
1 reference
Hideyuki Nomura
1 reference
Yuichi Tanabe
1 reference
Akihide Masumoto
1 reference
Toshihiro Maruyama
1 reference
Makoto Nakamuta
1 reference
Munechika Enjoji
1 reference
Koichi Azuma
1 reference
Junya Shimono
1 reference
Hironori Sakai
1 reference
Shinji Shimoda
1 reference
Jun Hayashi
1 reference
Kyushu University Liver Disease Study (KULDS) Group
1 reference
3 February 2008
1 reference
1 reference
23
1 reference
7 Pt 1
1 reference
1094-1104
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference